Evidence map›Paper›PMID 27914002›Full record

ArticleProbiotics and antimicrobial proteins2017

Phenotypic and Genotypic Characterization of Bacteriocinogenic Enterococci Against Clostridium botulinum.

Awad A Shehata, Reda Tarabees, Shereen Basiouni, Mahmoud Gamil, Ahmed S Kamal, Monika Krüger

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. What Is Wrong with Enterococcal Probiotics?Probiotics and antimicrobial proteins · 2020
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Awad A ShehataAvian and Rabbit Diseases Department, Faculty of Veterinary Medicine, Sadat City University, Sadat, Egypt. dr_awadali_1@yahoo.com.
Reda TarabeesDepartment of Bacteriology, Mycology and Immunology, Faculty of Veterinary medicine, Sadat City University, Sadat, Egypt.
Shereen BasiouniDepartment of Clinical Pathology, Faculty of Veterinary Medicine, Benha University, Benha, Qalioubeya, Egypt.
Mahmoud GamilAvian and Rabbit Diseases Department, Faculty of Veterinary Medicine, Sadat City University, Sadat, Egypt.
Ahmed S KamalAvian and Rabbit Diseases Department, Faculty of Veterinary Medicine, Sadat City University, Sadat, Egypt.
Monika KrügerAlbrecht-Daniel-Thaer-Institute, Faculty of Veterinary Medicine, Leipzig Universitty, Leipzig, Germany.
University of Sadat City · EGBenha University · EGLeipzig University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to characterize Enterococcus faecalis (n = -6) and Enterococcus faecium (n = 1) isolated from healthy chickens to find a novel perspective probiotic candidate that antagonize Clostridium botulinum types A, B, D, and E. The isolated enterococci were characterized based on phenotypic properties, PCR, and matrix-assisted laser desorption/ionization time of flight (MALDI-TOF). The virulence determinants including hemolytic activity on blood agar, gelatinase activity, sensitivity to vancomycin, and presence of gelatinase (gelE) and enterococcal surface protein (esp) virulence genes were investigated. Also, the presence of enterocin structural genes enterocin A, enterocin B, enterocin P, enterocin L50A/B, bacteriocin 31, enterocin AS48, enterocin 1071A/1071B, and enterocin 96 were assessed using PCR. Lastly, the antagonistic effect of the selected Enterococcus spp. on the growth of C. botulinum types A, B, D, and E was studied. The obtained results showed that four out of six E. faecalis and one E. faecium proved to be free from the tested virulence markers. All tested enterococci strains exhibited more than one of the tested enterocin. Interestingly, E. faecalis and E. faecium significantly restrained the growth of C. botulinum types A, B, D, and E. In conclusion, although, the data presented showed that bacteriocinogenic Enterococcus strains lacking of virulence determinants could be potentially used as a probiotic candidate against C. botulinum in vitro; however, further investigations are still urgently required to verify the beneficial effects of the tested Enterococcus spp. in vivo.

Indexed as

AnimalsBacterial ProteinsBacteriocinsChickensClostridium botulinumEnterococcus faecalisEnterococcus faeciumGenotypePhenotypeProbioticsBacterial ProteinsBacteriocinsClostridium botulinumEnterocinEnterococcusMALDI-TOFPCRProbioticsVirulence markers

Identifiers

PMID27914002
OpenAlexW2558046544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.